Skip to search boxSkip to navigationSkip to main content

Ganglioside alterations in guinea pig brains at end stages of experimental Creutzfeldt-Jakob disease

  • Robert K. Yu(corresponding author)
    ,
  • Elias E. Manuelidis
*Corresponding author for this work
  • Yale University
Scholary Output:
Contribution to journal
Article
Peer-review

Open access

Abstract

Gangliosides were isolated from guinea pig brains at the end stages of experimental Creutzfeldt-Jakob disease. Quantitative analyses revealed marked decreases of ganglioside levels in pathologically devastated tissues such as cerebral cortex (-21%), basal ganglia and thalamus (-18%), and brain stem (-23%). The cerebellum revealed only minor pathological abnormalities and its ganglioside level remained unchanged. Thin-layer chromatography of the Creutzfeldt-Jakob brain gangliosides showed aberrant ganglioside patterns in all regions studied, including the cerebellum. With some exceptions, a trend in ganglioside pattern changes was detected which consisted of proliferation of GM3, GD3, GD2 and loss of GM1, GD1a, GD1b and GT1b** ** The ganglioside nomenclature system of Svennerholm (1963) is used. The structures of some of the gangliosides have been compiled recently (Ledeen and Yu 1976)..

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 15-23 (9 pages)

Journal (Volume, Issue Number)

Journal of the Neurological Sciences (Volume 35, Issue 1)

Publication milestones

  • Published - 01/1978

Publication status

Published - 01/1978

ISSN

0022-510X

Publication IDs

  • Scopus: 0017927888
  • PubMed: 342675

Publication metrics

Metrics

Fractional count
1
Fractional count
0.50
Fractional count
1
Fractional count
0.50
Fractional count
1
Fractional count
1
Scopus
citations

PlumX, opens in new tab

Captures
6
Citation count
21

Funding Details

This work was supported by USPHS Grants NS-11853 and NS-12674, and in part by grants from The Kroc Foundation and The Klingenstein Fund.